nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Epinephrine—TNF—psoriatic arthritis	0.00372	1	CrCbGaD
Carbidopa—Hypertension—Prednisolone—psoriatic arthritis	0.00234	0.00235	CcSEcCtD
Carbidopa—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00231	0.00232	CcSEcCtD
Carbidopa—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Carbidopa—Alopecia—Dexamethasone—psoriatic arthritis	0.00229	0.0023	CcSEcCtD
Carbidopa—Alopecia—Betamethasone—psoriatic arthritis	0.00229	0.0023	CcSEcCtD
Carbidopa—Discomfort—Prednisolone—psoriatic arthritis	0.00228	0.00229	CcSEcCtD
Carbidopa—Angioedema—Triamcinolone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Carbidopa—Haemoglobin—Prednisone—psoriatic arthritis	0.00227	0.00228	CcSEcCtD
Carbidopa—Angioedema—Methylprednisolone—psoriatic arthritis	0.00227	0.00228	CcSEcCtD
Carbidopa—Haemorrhage—Prednisone—psoriatic arthritis	0.00226	0.00227	CcSEcCtD
Carbidopa—Hallucination—Prednisone—psoriatic arthritis	0.00225	0.00226	CcSEcCtD
Carbidopa—Malaise—Triamcinolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Carbidopa—Malaise—Methylprednisolone—psoriatic arthritis	0.00224	0.00225	CcSEcCtD
Carbidopa—Syncope—Triamcinolone—psoriatic arthritis	0.00223	0.00224	CcSEcCtD
Carbidopa—Syncope—Methylprednisolone—psoriatic arthritis	0.00223	0.00224	CcSEcCtD
Carbidopa—Oedema—Prednisolone—psoriatic arthritis	0.00221	0.00222	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00219	0.0022	CcSEcCtD
Carbidopa—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00219	0.0022	CcSEcCtD
Carbidopa—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00218	0.00219	CcSEcCtD
Carbidopa—Shock—Prednisolone—psoriatic arthritis	0.00217	0.00218	CcSEcCtD
Carbidopa—Cough—Triamcinolone—psoriatic arthritis	0.00217	0.00218	CcSEcCtD
Carbidopa—Convulsion—Triamcinolone—psoriatic arthritis	0.00216	0.00217	CcSEcCtD
Carbidopa—Convulsion—Methylprednisolone—psoriatic arthritis	0.00215	0.00216	CcSEcCtD
Carbidopa—Hypertension—Triamcinolone—psoriatic arthritis	0.00215	0.00216	CcSEcCtD
Carbidopa—Hypertension—Methylprednisolone—psoriatic arthritis	0.00214	0.00215	CcSEcCtD
Carbidopa—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Carbidopa—Anxiety—Methylprednisolone—psoriatic arthritis	0.00211	0.00212	CcSEcCtD
Carbidopa—Depression—Methotrexate—psoriatic arthritis	0.0021	0.00211	CcSEcCtD
Carbidopa—Flushing—Prednisone—psoriatic arthritis	0.0021	0.00211	CcSEcCtD
Carbidopa—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Carbidopa—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Carbidopa—Discomfort—Triamcinolone—psoriatic arthritis	0.00209	0.0021	CcSEcCtD
Carbidopa—Discomfort—Methylprednisolone—psoriatic arthritis	0.00209	0.0021	CcSEcCtD
Carbidopa—Dry mouth—Triamcinolone—psoriatic arthritis	0.00207	0.00208	CcSEcCtD
Carbidopa—Angioedema—Dexamethasone—psoriatic arthritis	0.00206	0.00207	CcSEcCtD
Carbidopa—Angioedema—Betamethasone—psoriatic arthritis	0.00206	0.00207	CcSEcCtD
Carbidopa—Confusional state—Methylprednisolone—psoriatic arthritis	0.00204	0.00205	CcSEcCtD
Carbidopa—Malaise—Dexamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Carbidopa—Malaise—Betamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Carbidopa—Oedema—Triamcinolone—psoriatic arthritis	0.00203	0.00204	CcSEcCtD
Carbidopa—Syncope—Betamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Carbidopa—Syncope—Dexamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Carbidopa—Infection—Triamcinolone—psoriatic arthritis	0.00202	0.00203	CcSEcCtD
Carbidopa—Infection—Methylprednisolone—psoriatic arthritis	0.00201	0.00202	CcSEcCtD
Carbidopa—Shock—Triamcinolone—psoriatic arthritis	0.002	0.00201	CcSEcCtD
Carbidopa—Insomnia—Prednisolone—psoriatic arthritis	0.002	0.00201	CcSEcCtD
Carbidopa—Alopecia—Prednisone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Carbidopa—Shock—Methylprednisolone—psoriatic arthritis	0.00199	0.002	CcSEcCtD
Carbidopa—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Carbidopa—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Carbidopa—Paraesthesia—Prednisolone—psoriatic arthritis	0.00198	0.00199	CcSEcCtD
Carbidopa—Mental disorder—Prednisone—psoriatic arthritis	0.00198	0.00199	CcSEcCtD
Carbidopa—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00196	0.00197	CcSEcCtD
Carbidopa—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00196	0.00197	CcSEcCtD
Carbidopa—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00196	0.00197	CcSEcCtD
Carbidopa—Convulsion—Betamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Carbidopa—Convulsion—Dexamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Carbidopa—Hypertension—Dexamethasone—psoriatic arthritis	0.00195	0.00196	CcSEcCtD
Carbidopa—Hypertension—Betamethasone—psoriatic arthritis	0.00195	0.00196	CcSEcCtD
Carbidopa—Anxiety—Betamethasone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Carbidopa—Anxiety—Dexamethasone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Carbidopa—Discomfort—Betamethasone—psoriatic arthritis	0.0019	0.00191	CcSEcCtD
Carbidopa—Discomfort—Dexamethasone—psoriatic arthritis	0.0019	0.00191	CcSEcCtD
Carbidopa—Haemoglobin—Methotrexate—psoriatic arthritis	0.0019	0.00191	CcSEcCtD
Carbidopa—Hypotension—Methylprednisolone—psoriatic arthritis	0.00189	0.0019	CcSEcCtD
Carbidopa—Pain—Prednisolone—psoriatic arthritis	0.00189	0.0019	CcSEcCtD
Carbidopa—Haemorrhage—Methotrexate—psoriatic arthritis	0.00189	0.0019	CcSEcCtD
Carbidopa—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Carbidopa—Vision blurred—Prednisone—psoriatic arthritis	0.00185	0.00186	CcSEcCtD
Carbidopa—Urethral disorder—Methotrexate—psoriatic arthritis	0.00185	0.00186	CcSEcCtD
Carbidopa—Oedema—Dexamethasone—psoriatic arthritis	0.00184	0.00185	CcSEcCtD
Carbidopa—Oedema—Betamethasone—psoriatic arthritis	0.00184	0.00185	CcSEcCtD
Carbidopa—Insomnia—Triamcinolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Carbidopa—Insomnia—Methylprednisolone—psoriatic arthritis	0.00183	0.00184	CcSEcCtD
Carbidopa—Infection—Dexamethasone—psoriatic arthritis	0.00183	0.00184	CcSEcCtD
Carbidopa—Infection—Betamethasone—psoriatic arthritis	0.00183	0.00184	CcSEcCtD
Carbidopa—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Carbidopa—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00182	0.00183	CcSEcCtD
Carbidopa—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00182	0.00183	CcSEcCtD
Carbidopa—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00182	0.00183	CcSEcCtD
Carbidopa—Anaemia—Prednisone—psoriatic arthritis	0.00182	0.00183	CcSEcCtD
Carbidopa—Shock—Dexamethasone—psoriatic arthritis	0.00181	0.00182	CcSEcCtD
Carbidopa—Shock—Betamethasone—psoriatic arthritis	0.00181	0.00182	CcSEcCtD
Carbidopa—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00181	0.00182	CcSEcCtD
Carbidopa—Agitation—Prednisone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Carbidopa—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Carbidopa—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Carbidopa—Angioedema—Prednisone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Carbidopa—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00179	0.0018	CcSEcCtD
Carbidopa—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00178	0.00179	CcSEcCtD
Carbidopa—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00178	0.00179	CcSEcCtD
Carbidopa—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00178	0.00179	CcSEcCtD
Carbidopa—Malaise—Prednisone—psoriatic arthritis	0.00177	0.00178	CcSEcCtD
Carbidopa—Syncope—Prednisone—psoriatic arthritis	0.00176	0.00177	CcSEcCtD
Carbidopa—Anorexia—Betamethasone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Carbidopa—Anorexia—Dexamethasone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Carbidopa—Urticaria—Prednisolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Carbidopa—Fatigue—Triamcinolone—psoriatic arthritis	0.00175	0.00176	CcSEcCtD
Carbidopa—Fatigue—Methylprednisolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Carbidopa—Pain—Triamcinolone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Carbidopa—Loss of consciousness—Prednisone—psoriatic arthritis	0.00173	0.00174	CcSEcCtD
Carbidopa—Hypotension—Dexamethasone—psoriatic arthritis	0.00172	0.00173	CcSEcCtD
Carbidopa—Hypotension—Betamethasone—psoriatic arthritis	0.00172	0.00173	CcSEcCtD
Carbidopa—Convulsion—Prednisone—psoriatic arthritis	0.0017	0.00171	CcSEcCtD
Carbidopa—Hypertension—Prednisone—psoriatic arthritis	0.0017	0.00171	CcSEcCtD
Carbidopa—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00167	0.00168	CcSEcCtD
Carbidopa—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00167	0.00168	CcSEcCtD
Carbidopa—Anxiety—Prednisone—psoriatic arthritis	0.00167	0.00168	CcSEcCtD
Carbidopa—Alopecia—Methotrexate—psoriatic arthritis	0.00167	0.00168	CcSEcCtD
Carbidopa—Insomnia—Dexamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Carbidopa—Insomnia—Betamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Carbidopa—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Carbidopa—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Carbidopa—Paraesthesia—Betamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Carbidopa—Discomfort—Prednisone—psoriatic arthritis	0.00165	0.00166	CcSEcCtD
Carbidopa—Mental disorder—Methotrexate—psoriatic arthritis	0.00165	0.00166	CcSEcCtD
Carbidopa—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Carbidopa—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00162	0.00163	CcSEcCtD
Carbidopa—Dyspepsia—Betamethasone—psoriatic arthritis	0.00162	0.00163	CcSEcCtD
Carbidopa—Urticaria—Triamcinolone—psoriatic arthritis	0.00161	0.00162	CcSEcCtD
Carbidopa—Urticaria—Methylprednisolone—psoriatic arthritis	0.00161	0.00162	CcSEcCtD
Carbidopa—Dysgeusia—Methotrexate—psoriatic arthritis	0.00161	0.00162	CcSEcCtD
Carbidopa—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Carbidopa—Oedema—Prednisone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Carbidopa—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.0016	0.00161	CcSEcCtD
Carbidopa—Decreased appetite—Dexamethasone—psoriatic arthritis	0.0016	0.00161	CcSEcCtD
Carbidopa—Decreased appetite—Betamethasone—psoriatic arthritis	0.0016	0.00161	CcSEcCtD
Carbidopa—Infection—Prednisone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00159	0.0016	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00159	0.0016	CcSEcCtD
Carbidopa—Back pain—Methotrexate—psoriatic arthritis	0.00159	0.0016	CcSEcCtD
Carbidopa—Fatigue—Dexamethasone—psoriatic arthritis	0.00159	0.0016	CcSEcCtD
Carbidopa—Fatigue—Betamethasone—psoriatic arthritis	0.00159	0.0016	CcSEcCtD
Carbidopa—Shock—Prednisone—psoriatic arthritis	0.00158	0.00159	CcSEcCtD
Carbidopa—Pain—Dexamethasone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Carbidopa—Pain—Betamethasone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Carbidopa—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00155	0.00156	CcSEcCtD
Carbidopa—Vision blurred—Methotrexate—psoriatic arthritis	0.00155	0.00156	CcSEcCtD
Carbidopa—Anorexia—Prednisone—psoriatic arthritis	0.00153	0.00154	CcSEcCtD
Carbidopa—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Carbidopa—Anaemia—Methotrexate—psoriatic arthritis	0.00152	0.00153	CcSEcCtD
Carbidopa—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00152	0.00153	CcSEcCtD
Carbidopa—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00152	0.00153	CcSEcCtD
Carbidopa—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Carbidopa—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Carbidopa—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Carbidopa—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00149	0.0015	CcSEcCtD
Carbidopa—Malaise—Methotrexate—psoriatic arthritis	0.00148	0.00149	CcSEcCtD
Carbidopa—Leukopenia—Methotrexate—psoriatic arthritis	0.00147	0.00148	CcSEcCtD
Carbidopa—Urticaria—Dexamethasone—psoriatic arthritis	0.00146	0.00147	CcSEcCtD
Carbidopa—Urticaria—Betamethasone—psoriatic arthritis	0.00146	0.00147	CcSEcCtD
Carbidopa—Dizziness—Prednisolone—psoriatic arthritis	0.00146	0.00147	CcSEcCtD
Carbidopa—Asthenia—Triamcinolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Carbidopa—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Carbidopa—Body temperature increased—Betamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Carbidopa—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Carbidopa—Abdominal pain—Betamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Carbidopa—Asthenia—Methylprednisolone—psoriatic arthritis	0.00145	0.00146	CcSEcCtD
Carbidopa—Insomnia—Prednisone—psoriatic arthritis	0.00145	0.00146	CcSEcCtD
Carbidopa—Paraesthesia—Prednisone—psoriatic arthritis	0.00144	0.00145	CcSEcCtD
Carbidopa—Pruritus—Triamcinolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Carbidopa—Cough—Methotrexate—psoriatic arthritis	0.00143	0.00144	CcSEcCtD
Carbidopa—Pruritus—Methylprednisolone—psoriatic arthritis	0.00143	0.00144	CcSEcCtD
Carbidopa—Convulsion—Methotrexate—psoriatic arthritis	0.00142	0.00143	CcSEcCtD
Carbidopa—Dyspepsia—Prednisone—psoriatic arthritis	0.00141	0.00142	CcSEcCtD
Carbidopa—Chest pain—Methotrexate—psoriatic arthritis	0.0014	0.00141	CcSEcCtD
Carbidopa—Decreased appetite—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Carbidopa—Rash—Prednisolone—psoriatic arthritis	0.00139	0.0014	CcSEcCtD
Carbidopa—Dermatitis—Prednisolone—psoriatic arthritis	0.00139	0.0014	CcSEcCtD
Carbidopa—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Carbidopa—Fatigue—Prednisone—psoriatic arthritis	0.00138	0.00139	CcSEcCtD
Carbidopa—Headache—Prednisolone—psoriatic arthritis	0.00138	0.00139	CcSEcCtD
Carbidopa—Discomfort—Methotrexate—psoriatic arthritis	0.00138	0.00139	CcSEcCtD
Carbidopa—Constipation—Prednisone—psoriatic arthritis	0.00137	0.00138	CcSEcCtD
Carbidopa—Confusional state—Methotrexate—psoriatic arthritis	0.00135	0.00136	CcSEcCtD
Carbidopa—Dizziness—Triamcinolone—psoriatic arthritis	0.00134	0.00135	CcSEcCtD
Carbidopa—Dizziness—Methylprednisolone—psoriatic arthritis	0.00134	0.00135	CcSEcCtD
Carbidopa—Infection—Methotrexate—psoriatic arthritis	0.00133	0.00134	CcSEcCtD
Carbidopa—Feeling abnormal—Prednisone—psoriatic arthritis	0.00132	0.00133	CcSEcCtD
Carbidopa—Asthenia—Dexamethasone—psoriatic arthritis	0.00132	0.00133	CcSEcCtD
Carbidopa—Asthenia—Betamethasone—psoriatic arthritis	0.00132	0.00133	CcSEcCtD
Carbidopa—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00131	0.00132	CcSEcCtD
Carbidopa—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00131	0.00132	CcSEcCtD
Carbidopa—Nausea—Prednisolone—psoriatic arthritis	0.00131	0.00132	CcSEcCtD
Carbidopa—Pruritus—Dexamethasone—psoriatic arthritis	0.0013	0.00131	CcSEcCtD
Carbidopa—Pruritus—Betamethasone—psoriatic arthritis	0.0013	0.00131	CcSEcCtD
Carbidopa—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Carbidopa—Vomiting—Triamcinolone—psoriatic arthritis	0.00129	0.0013	CcSEcCtD
Carbidopa—Vomiting—Methylprednisolone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Carbidopa—Rash—Triamcinolone—psoriatic arthritis	0.00128	0.00129	CcSEcCtD
Carbidopa—Dermatitis—Triamcinolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Carbidopa—Anorexia—Methotrexate—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Carbidopa—Rash—Methylprednisolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Carbidopa—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Carbidopa—Urticaria—Prednisone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Carbidopa—Headache—Triamcinolone—psoriatic arthritis	0.00127	0.00128	CcSEcCtD
Carbidopa—Headache—Methylprednisolone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Carbidopa—Body temperature increased—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Carbidopa—Abdominal pain—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Carbidopa—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00126	0.00127	CcSEcCtD
Carbidopa—Diarrhoea—Betamethasone—psoriatic arthritis	0.00126	0.00127	CcSEcCtD
Carbidopa—Hypotension—Methotrexate—psoriatic arthritis	0.00125	0.00126	CcSEcCtD
Carbidopa—Dizziness—Dexamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Carbidopa—Dizziness—Betamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Carbidopa—Insomnia—Methotrexate—psoriatic arthritis	0.00121	0.00122	CcSEcCtD
Carbidopa—Nausea—Triamcinolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Carbidopa—Paraesthesia—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Carbidopa—Nausea—Methylprednisolone—psoriatic arthritis	0.0012	0.00121	CcSEcCtD
Carbidopa—Dyspnoea—Methotrexate—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Carbidopa—Somnolence—Methotrexate—psoriatic arthritis	0.00119	0.0012	CcSEcCtD
Carbidopa—Hypersensitivity—Prednisone—psoriatic arthritis	0.00118	0.00119	CcSEcCtD
Carbidopa—Dyspepsia—Methotrexate—psoriatic arthritis	0.00118	0.00119	CcSEcCtD
Carbidopa—Vomiting—Dexamethasone—psoriatic arthritis	0.00117	0.00118	CcSEcCtD
Carbidopa—Vomiting—Betamethasone—psoriatic arthritis	0.00117	0.00118	CcSEcCtD
Carbidopa—Decreased appetite—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Carbidopa—Rash—Betamethasone—psoriatic arthritis	0.00116	0.00117	CcSEcCtD
Carbidopa—Rash—Dexamethasone—psoriatic arthritis	0.00116	0.00117	CcSEcCtD
Carbidopa—Dermatitis—Betamethasone—psoriatic arthritis	0.00116	0.00117	CcSEcCtD
Carbidopa—Dermatitis—Dexamethasone—psoriatic arthritis	0.00116	0.00117	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Carbidopa—Fatigue—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Carbidopa—Headache—Betamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Carbidopa—Headache—Dexamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Carbidopa—Asthenia—Prednisone—psoriatic arthritis	0.00115	0.00116	CcSEcCtD
Carbidopa—Pain—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Carbidopa—Pruritus—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Carbidopa—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Carbidopa—Diarrhoea—Prednisone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Carbidopa—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Carbidopa—Nausea—Dexamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Carbidopa—Nausea—Betamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Carbidopa—Urticaria—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Carbidopa—Dizziness—Prednisone—psoriatic arthritis	0.00106	0.00107	CcSEcCtD
Carbidopa—Abdominal pain—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Carbidopa—Body temperature increased—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Carbidopa—Vomiting—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Carbidopa—Rash—Prednisone—psoriatic arthritis	0.00101	0.00102	CcSEcCtD
Carbidopa—Dermatitis—Prednisone—psoriatic arthritis	0.00101	0.00102	CcSEcCtD
Carbidopa—Headache—Prednisone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Carbidopa—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000989	0.000992	CcSEcCtD
Carbidopa—Asthenia—Methotrexate—psoriatic arthritis	0.000963	0.000966	CcSEcCtD
Carbidopa—Nausea—Prednisone—psoriatic arthritis	0.000954	0.000957	CcSEcCtD
Carbidopa—Pruritus—Methotrexate—psoriatic arthritis	0.000949	0.000953	CcSEcCtD
Carbidopa—Diarrhoea—Methotrexate—psoriatic arthritis	0.000918	0.000922	CcSEcCtD
Carbidopa—Dizziness—Methotrexate—psoriatic arthritis	0.000887	0.000891	CcSEcCtD
Carbidopa—Vomiting—Methotrexate—psoriatic arthritis	0.000853	0.000856	CcSEcCtD
Carbidopa—Rash—Methotrexate—psoriatic arthritis	0.000846	0.000849	CcSEcCtD
Carbidopa—Dermatitis—Methotrexate—psoriatic arthritis	0.000845	0.000849	CcSEcCtD
Carbidopa—Headache—Methotrexate—psoriatic arthritis	0.000841	0.000844	CcSEcCtD
Carbidopa—Nausea—Methotrexate—psoriatic arthritis	0.000797	0.0008	CcSEcCtD
